glp 1 competitors GLP-1 Receptor Agonist Market Size & Analysis, 2026-2033 Pharma Giants Bet on Next-Generation
Description
10.1016/S0140-6736(23)01200-X
Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins
Both drug classes demonstrate cardiovascular benefits, with SGLT2 inhibitors particularly effective for heart failure and GLP-1 receptor agonists reducing major adverse cardiovascular events
and Blanchard, R., 2005
